Metabolic syndrome Metabolic syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients providing written informed and consent to participate in the study 2) Aged >= 18 years (irrespective of sex) 3) Patients with Metabolic syndrome
Exclusion criteria
Exclusion criteria: 1) Patients with active or prior malignancy, heart failure, myocardial infarction. 2) Patients undergoing treatment for the following chronic diseases(excluded hypertension, dyslipidemia and diabetes). Arrhythmia, Liver disorder*, Renal disorder*, Cerebrovascular disorder, Rheumatoid arthritis, and other chronic diseases. * The following definitions shall be used for Liver and Renal disorder. - Liver disorder: AST and ALT are more than 3 times the upper limit of the (facility) reference value. - Renal disorder: Serum creatine >= 2.4 mg/dL (men), >= 2.0 mg/dL (women). 3) Patients with allergies (to medicines and test food related foods). 4) Patients with pregnancy, on breast-feeding or who wish to become pregnant during trial. 5) Current smoker in the 3 months prior to the date consent was obtained. 6) Patients registered in other clinical trials presently or within 3 months before acquisition consent of this trial. 7) Patients whom physician in charge considered inappropriate for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| %FMD at 14 days after the start of feeding | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Trigonelline value at 14 days after the start of feeding. 2) Lipid profile value at 14 days after the start of feeding. - Total cholesterol - Low density lipoprotein cholesterol - High density lipoprotein cholesterol - Triglyceride 3) Measured value at 14 days after the start of feeding. - Urine NOx - Urine 8-OhdG/Urine Creatinine ratio 4) Systolic blood pressure at 14 days after the start of feeding. 5) Diastolic blood pressure at 14 days after the start of feeding. | — |
Contacts
Kagoshima University Hospital